Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Inhaler and Bupropion for Smoking Cessation
NCT00033592Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 2002
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of nicotine, bupropion in Tobacco Use Disorder (TUD), sponsored by Cancer and Leukemia Group B. Started Feb 2002; status: completed.
02
Drugs
nicotinebupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00033592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033592.